Childhood sarcoidosis: Louisiana experience
Tóm tắt
A retrospective chart review was conducted to detect patients with sarcoidosis seen by pediatric rheumatology service from the period of 1992 to 2013 at Children’s hospital of New Orleans. Twenty-seven patients were identified. The average duration of symptoms before diagnosis was 5 (range 1–120) months. Five patients had onset before the age of 5 years and were diagnosed with early-onset sarcoidosis. The most common manifestations at presentation were constitutional symptoms (62 %) followed by ocular (38 %). During the course of illness, 19/27 (70 %) had multiorgan involvement. Common manifestations included uveitis/iritis (77 %), fever (50 %), hilar adenopathy (42 %), arthritis (31 %), peripheral lympadenopathy (31 %), hepatosplenomegaly (31 %), parenchymal lung disease (27 %), and skin rash (19 %). Unusual manifestations included granulomatous bone marrow disease (3 cases), hypertension (2), abdominal aortic aneurysm (large vessel vasculitis; 1), granulomatous hepatitis (1), nephrocalcinosis (1), membranous nephropathy (1), refractory granulomatous interstitial nephritis with recurrence in transplanted kidney (1), CNS involvement (2), parotid gland enlargement (1), and sensorineural hearing loss (1). Biopsy specimen was obtained in 21/27 (77 %) patients, and demonstration of noncaseating granuloma associated with negative stains for mycobacteria and fungi was seen in 18 patients. Elevated angiotensin-converting enzyme level was seen in 74 % of patients. Treatment with oral prednisone was initiated in symptomatic patients with significant clinical improvement. Low-dose methotrexate (MTX) 10–15 mg/m2/week orally, as steroid-sparing agent, was administered in 14 patients. Other immunomodulators included cyclophosphamide (2 patients), etanercept (2), infliximab (2), mycophenolate mofetil (1), and tacrolimus (1). Childhood sarcoidosis is prevalent in Louisiana. Most of the affected children present with a multisystem disease associated with manifestations similar to those of adult patients. Low-dose MTX seems to be effective, steroid sparing, and safe adjunct to treat sarcoidosis with multiorgan involvement. Early-onset disease is less common and associated with increased morbidity, flares, and poor prognosis.
Tài liệu tham khảo
Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement of sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173
Hoffman AL, Milman N, Byg KE (2004) Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr 93:30–36
Shetty AK, Gedalia A (2008) Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J 6:16
Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarcoidosis. J Pediatr 108:169–177
Kendig EL Jr (1989) Sarcoidosis in children. Personal observations on age distribution. Pediatric Pulmonol 6:69–70
Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829
Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarcoidosis. J Pediatr 108:169–177
Laghmari M, Skiker H, Boutimzine N, Daoudi R (2008) Uveitis during the course of sarcoidosis in a child: difficult diagnosis of a case. Bull Soc Belge Ophtalmol 307:47–51
Gedalia A, Shetty AK, Ward KJ, Correa H, Heinrich S (1997) Role of MRI in diagnosis of childhood sarcoidosis with fever of unknown origin. J Pediatr Orthop 17:460–462
Pattishall EN, Kendig EL Jr (1996) Sarcoidosis in children. Pediatr Pulmonol 22:195–203
Nocton JJ, Stork JE, Jacobs G, Newman AJ (1992) Sarcoidosis associated with nephrocalcinosis in young children. J Pediatr 121:937–940
Hafner R, Vogel P (1993) Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 11:685–691
Gedalia A, Shetty AK, Ward K, Correa H, Venters CL, Loe WA (1996) Abdominal aortic aneurysm associated with childhood sarcoidosis. J Rheumatol 23:757–759
Baumann RJ, Robertson WC (2003) Neurosarcoid presents differently in children than in adults. Pediatrics 112:e480–486
Shetty AK, Gedalia A (2000) Sarcoidosis in children. Curr Probl Pediatr 30:149–176
Rodriguez GE, Shin BC, Abernathy RS (1981) Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. J Pediatr 99:68–72
Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J (1990) Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. Clin Chem 36:344–346
Marcille R, McCarthy M, Barton JW, Merten DF, Spock A (1992) Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 102:1444–1449
Milman N, Hoffmann AL (2008) Childhood sarcoidosis: longterm follow-up. Eur Respir J 31:592–598
Milman N, Svendsen CB, Hoffmann AL (2009) Health-related quality of life in adult survivors of childhood sarcoidosis. Respir Med 103:913–918
Gedalia A, Molina JF, Ellis GS Jr, Galen W, Moore C, Espinoza LR (1997) Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr 130:25–29